APA

Fagerberg J., Frödin J. E., Wigzell H. & Mellstedt H. (19930915). Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?. : Cancer immunology, immunotherapy : CII.

Chicago

Fagerberg J, Frödin J E, Wigzell H and Mellstedt H. 19930915. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?. : Cancer immunology, immunotherapy : CII.

Harvard

Fagerberg J., Frödin J. E., Wigzell H. and Mellstedt H. (19930915). Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?. : Cancer immunology, immunotherapy : CII.

MLA

Fagerberg J, Frödin J E, Wigzell H and Mellstedt H. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?. : Cancer immunology, immunotherapy : CII. 19930915.